VivoSeq
Other

Gastrointestinal Dysfunction

0

Pipeline Programs↗

2

Active Trials↗

4

Companies Involved↗

Gastrointestinal Dysfunction is an early-stage landscape with 0 programs across 4 companies. The most active players are Shandong New Time Pharmaceutical Co., LTD, Takeda, UCB.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

Shandong New Time Pharmaceutical Co., LTD

0 programs

PreclinicalTakeda logo

Takeda

0 programs

PreclinicalUCB logo

UCB

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed3 · 50%
Recruiting1 · 17%
Terminated1 · 17%
Not yet recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction
Recruiting·SShandong New Time Pharmaceutical Co., LTD·Phase 2·NCT06782594·150 enrolled
A Single-Center,Randomized Controlled Study on Neostigmine Acupoint Injection at Zusanli(ST36) for Treating Mechanical Ventilation-Associated Gastrointestinal Dysfunction
Not yet recruiting·SSoutheast University, China·Preclinical·NCT07692282·90 enrolled
A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery
Completed·Takeda logoTakeda·Phase 2·NCT03827655·209 enrolled
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
Completed·Merck & Co. logoMerck & Co.·Phase 4·NCT00686543·75 enrolled
Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment
Completed·—·Phase 2·NCT01993680·18 enrolled
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Terminated·UCB logoUCB·Phase 3·NCT01536015·25 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)